University of Michigan: New Nanoparticle Developed for Intravenous Cancer Immunotherapy
October 01, 2021
October 01, 2021
ANN ARBOR, Michigan, Oct. 1 (TNSJou) -- The University of Michigan issued the following news release:
Cancer immunotherapy seeks to turn "cold" tumors into "hot" tumors--those that respond to immunotherapy--by awakening and enlisting the body's own immune system.
Unfortunately, few people benefit from the most common form of immunotherapy, called immune checkpoint inhibitors, and scientists are actively seeking new and safe molecules called agon . . .
Cancer immunotherapy seeks to turn "cold" tumors into "hot" tumors--those that respond to immunotherapy--by awakening and enlisting the body's own immune system.
Unfortunately, few people benefit from the most common form of immunotherapy, called immune checkpoint inhibitors, and scientists are actively seeking new and safe molecules called agon . . .